Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viswanath Das

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The FEBS Journal|November 7, 2021
Antitumour drugs targeting tau R3 VQIVYK and Cys322 prevent seeding of endogenous tau aggregates by exogenous seedsNarendran Annadurai, Lukáš Malina, Mario Salmona, et al.
Bioorganic Chemistry|March 4, 2025
Identification of a novel Azaspirooxindolinone-based PROTAC for selective BTK degradation and enhanced anticancer activityNaveen Kumar Rampeesa, Rambabu Gundla, Gopal Mudasani, et al.
Chembiochem : a European Journal of Chemical Biology|May 3, 2021
Inhibitors of CA IX Enzyme Based on Polyhedral Boron CompoundsMichael Kugler, Jan Nekvinda, Josef Holub, et al.
The FEBS Journal|August 17, 2025
Hydrophobic residues in the α-synuclein NAC domain drive seed-competent fibril formation and are targeted by peptide inhibitorsViswanath Das, Sayed Mostafa Modarres Mousavi, Narendran Annadurai, et al.
European Journal of Medicinal Chemistry|September 29, 2022
Triterpenoid pyrazines and pyridines - Synthesis, cytotoxicity, mechanism of action, preparation of prodrugsJiří Hodoň, Ivo Frydrych, Zdeňka Trhlíková, et al.
European Journal of Medicinal Chemistry|June 8, 2020
Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IXJana Dvořanová, Michael Kugler, Josef Holub, et al.
Journal of Medicinal Chemistry|October 1, 2019
Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IXBohumír Grüner, Jiří Brynda, Viswanath Das, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The FEBS Journal|November 7, 2021
Antitumour drugs targeting tau R3 VQIVYK and Cys322 prevent seeding of endogenous tau aggregates by exogenous seedsNarendran Annadurai, Lukáš Malina, Mario Salmona, et al.
Bioorganic Chemistry|March 4, 2025
Identification of a novel Azaspirooxindolinone-based PROTAC for selective BTK degradation and enhanced anticancer activityNaveen Kumar Rampeesa, Rambabu Gundla, Gopal Mudasani, et al.
Chembiochem : a European Journal of Chemical Biology|May 3, 2021
Inhibitors of CA IX Enzyme Based on Polyhedral Boron CompoundsMichael Kugler, Jan Nekvinda, Josef Holub, et al.
The FEBS Journal|August 17, 2025
Hydrophobic residues in the α-synuclein NAC domain drive seed-competent fibril formation and are targeted by peptide inhibitorsViswanath Das, Sayed Mostafa Modarres Mousavi, Narendran Annadurai, et al.
European Journal of Medicinal Chemistry|September 29, 2022
Triterpenoid pyrazines and pyridines - Synthesis, cytotoxicity, mechanism of action, preparation of prodrugsJiří Hodoň, Ivo Frydrych, Zdeňka Trhlíková, et al.
European Journal of Medicinal Chemistry|June 8, 2020
Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IXJana Dvořanová, Michael Kugler, Josef Holub, et al.
Journal of Medicinal Chemistry|October 1, 2019
Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IXBohumír Grüner, Jiří Brynda, Viswanath Das, et al.
Pageof 4